R Squared’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-650
Closed -$14.6K 651
2024
Q4
$14.6K Buy
+650
New +$14.6K 0.01% 1022